Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00227682 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Terminated early due to funding suspension by grant sponsor.

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DIETARY_SUPPLEMENT: ascorbic acid
DRUG: arsenic trioxide
DRUG: dexamethasone
DRUG: thalidomide

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]